Clinically significant safety concerns include heart rate elevation, risk of hypoglycaemia when combined with insulin or sulfonylureas, delayed gastric emptying, and a class-relevant caution regarding thyroid C-cell tumours
Thyroid medication increases heart muscle contractions through genomic effects (slow, dose-dependent changes to gene expression) and non-genomic effects (immediate changes when hormone enters bloodstream)
The potential advent of an effective tau-directed disease-targeted therapies (DTTs) for AD may increase the volume of patients presenting earlier in the disease continuum, and increase complexity in workflow, infrastructure, treatment decision-making, treatment administration and monitoring, and patient tracking
The actual treatment will depend on the source and cause of bleeding
During intense physical activity, your body burns through it quickly
Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease